Premium
Food and Drug Administration approval of sustained‐release buprenorphine for treatment of opioid dependence: realizing its potential
Author(s) -
Sigmon Stacey C.,
Bigelow George E.
Publication year - 2017
Publication title -
addiction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.424
H-Index - 193
eISSN - 1360-0443
pISSN - 0965-2140
DOI - 10.1111/add.13539
Subject(s) - buprenorphine , medicine , naltrexone , opioid , opioid use disorder , medical prescription , substance abuse , drug , fentanyl , intensive care medicine , pharmacology , psychiatry , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom